Developments in the pathology of ovarian tumours

被引:10
作者
Chapman, WB [1 ]
机构
[1] Univ Toronto, Dept Lab Med & Pathobiol & Obstet & Gynecol, Toronto, ON, Canada
关键词
D O I
10.1097/00001703-200102000-00008
中图分类号
R71 [妇产科学];
学科分类号
100211 ;
摘要
The understanding of the pathogenesis and pathology of ovarian tumours is constantly evolving. Dominant themes in recent studies of ovarian tumours include prognostic features in borderline tumours, molecular events in the pathogenesis of ovarian tumours, the assessment of tumour features that may have prognostic or treatment implications, and the development of techniques that may enhance diagnostic accuracy. The literature has been reviewed with an aim to identifying those studies that can potentially impact practice and improve patient care. The most noteworthy developments include: the understanding that so-called 'tumours of low malignant potential' are virtually always benign, and that one can identify those rare cases with malignant potential; the importance of the recognition of micropapillary serous carcinomas; an improved understanding of early invasive carcinomas and their impact on screening practices; an understanding of the association of endometriosis with ovarian cancer; further awareness of factors in ovarian tumours that influence prognosis, such as refinements in grading and molecular markers such as P27; and refinements in diagnosis so as to distinguish primary from metastatic cancer and benign lesions from malignant tumours more effectively. Curr Opin Obstet Gynecol 13:53-59. (C) 2001 Lippincott Williams & Wilkins.
引用
收藏
页码:53 / 59
页数:7
相关论文
共 54 条
[1]   Differential expression of MUC2 and MUC5AC mucin genes in primary ovarian and metastatic colonic carcinoma [J].
Albarracin, CT ;
Jafri, J ;
Montag, AG ;
Hart, J ;
Kuan, SF .
HUMAN PATHOLOGY, 2000, 31 (06) :672-677
[2]  
BELL DA, 1994, CANCER, V73, P1859, DOI 10.1002/1097-0142(19940401)73:7<1859::AID-CNCR2820730714>3.0.CO
[3]  
2-L
[4]  
BELL DA, 1988, CANCER, V62, P2212, DOI 10.1002/1097-0142(19881115)62:10<2212::AID-CNCR2820621024>3.0.CO
[5]  
2-W
[6]   OVARIAN SEROUS BORDERLINE TUMORS WITH STROMAL MICROINVASION - A REPORT OF 21 CASES [J].
BELL, DA ;
SCULLY, RE .
HUMAN PATHOLOGY, 1990, 21 (04) :397-403
[7]  
Berezowski K, 1996, MODERN PATHOL, V9, P426
[8]   Cancer risk after a hospital discharge diagnosis of endometriosis [J].
Brinton, LA ;
Gridley, G ;
Persson, I ;
Baron, J ;
Bergqvist, A .
AMERICAN JOURNAL OF OBSTETRICS AND GYNECOLOGY, 1997, 176 (03) :572-579
[9]   Micropapillary serous carcinoma of the ovary - A distinctive low-grade carcinoma related to serous borderline tumors [J].
Burks, RT ;
Sherman, ME ;
Kurman, RJ .
AMERICAN JOURNAL OF SURGICAL PATHOLOGY, 1996, 20 (11) :1319-1330
[10]   Comparison of mutations of Ki-RAS and p53 immunoreactivity in borderline and malignant epithelial ovarian tumors [J].
Caduff, RF ;
Svoboda-Newman, SM ;
Ferguson, AW ;
Johnston, CN ;
Frank, TS .
AMERICAN JOURNAL OF SURGICAL PATHOLOGY, 1999, 23 (03) :323-328